Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nothing we can do about the share price! But PLS Don't let them manipulate your mind.
Keep the faith.
Nothing proves the technology we have does not work!
Man, ppl are just like you. See the downshift of the share prices and thinking the sky is falling. :)
OT: GNVC is back to life, hopefully, COR will rebound and restart its uptrend soon.
We can only wait.
Just because the share price goes lower does not mean any of the following is no longer true:
- Excellent ADHD result
- Great Sleeping trial (- whatever happening in DARPA)
- Clean data which lift the hold
- Great finding in High Impact
- Couple more low impacts coming
- For-coming BP deal.
For every seller there is buyer. At this price, buying is the wiser thing to do for sure. IMO.
Keep the faith!
I don't think the recent downshift is related to DARPA at all.
Many shares go by without showing up on the BID and ASK.
IMO, three factors for the selling:
1. margined shares are forced to be sold.
2. Disappointment in the share price action after the hold is the no.1 factor to cause the further downshift.
3. tax loss selling.
4. Someone is using this quiet period
Thanks for the seller who is willing to dump 1 million to stop our move.
Imagine that 50% cut for getting the hold. Now basically nothing for lifting it.
I hoped I didn't buy after the hold. But who knows, COR often make the biggest rise after everybody is feeling piss off with the share price.
2.84 - BODs will never do a PIPE is the BP talk is resumed and we will know soon enough!
STILL HOPEFUL.
With the lifting of the hold and excellent ADHD result.
I don't see any reason of selling at all.
Everything seems to be fine except the share price which is fine!
Happy days ahead.
Hope we go up tmw. This is amazing.
Hopefully, the CC will clarify:
- What's the limited dosing range.
- The status on BP deal.
- Cash position and hopefully some hints on financing.
- Comments on lagging share price.
average trade price: 3.44
Btw, I will keep adding.
From LA times, it explains why CX717 alone worth more than current market cap.
Cortex Pharmaceuticals Inc. shares rose 9% on Monday after the Irvine-based company said U.S. regulators had approved the resumption of clinical trials on a compound designed to help people stay awake.
The Food and Drug Administration told Cortex on Friday that the agency had lifted a hold placed almost seven months earlier on trials of the company's ampakine CX717 compound, Cortex said.
The delay in the stay-awake study disrupted Cortex's plans to find a partner to market the compound for treatment of attention deficit hyperactivity disorder, or ADHD, an indication that it was far along in human trials, said Elemer Piros, an analyst at Rodman & Renshaw Inc. in New York.
"You can sort of gauge the interest from the pharmaceutical industry in a compound that has a friendlier label for ADHD," Piros said. "You don't want to feed millions of Americans with stimulants and derivatives if you have a choice. Cortex may provide that alternative."
If approved, the drug probably wouldn't be subject to regulation by law enforcement agencies because it isn't a stimulant, Piros said.
Cortex shares rose 28 cents to close at $3.39, after touching $3.81 earlier in the day. The company's shares had risen 35% this year through Friday.
The company made a commitment to use FDA-specified doses in the wakefulness trials, the statement said. Cortex also plans to have more extensive toxicological information available after a three-month study in monkeys and rats is completed this year, the company said.
Cortex's products in development are all from the ampakine family of compounds, which is said to boost the function of a neurotransmitter called glutamate. When that improves, brain cells can carry signals more effectively, potentially helpful in treating ADHD, the company said.
The company said the drug might also be used to treat patients with memory and cognition problems, autism, Alzheimer's disease, schizophrenia and depression.
Facts.
We traded above 4 (just few hundreds) pre-market. Someone dumped 60k share @3.49 for some reasons. I had a bid of 3.7 at that time, got filled at 3.49. (still underwater).
Average trading price: above 3.5
neuoinv, are u disappointed today?
Stoll and his team - Well done. Share price will take care itself given Cortex can do tons of things outlines in recent ASM and CCs.
I like this price alot. Almost no downside risk and huge upside potential.
I am In and will be all in.
Recent financing.
MEMY - done at 1.11, now share at 1.44.
ACOR - done at around 9.25.
What i am trying to say is financing doesn't necessary bring the pps lower.
WATCH OUT.
I expected pps will be north of 4 after the hold is lifted.
I am dead wrong on that. What's wrong.
i expect those holders won't until dec to sell those shares.
aiming, no one can't predict share price tmw, let alone 3 months later.
remmeber u predict cor's pps will go to near sub 2 before the hold lift? that never come.
I buy when i think it's cheap. it's very cheap right now.
10 days later we will have a CC. Things will be clear up. As long as BP deal is on-going. We will be good.
Tax loss selling - over 5 trading is around 3million shares only. I expect less than 1 million still hold underwater shares.
tax loss selling? u got to be kidding. We are still trading higher year over year.
this price is BS, 3 months from now, we will be over 5.
Buying now will be a wise thing to do
And I am doing it RIGHT NOW.
I am pissed.
cheap as dust.
the hold is lifted means the data is clean.
higher dose on human trial is expected to be discussed with FDA anyways. I bot more today and will keep adding.
Blocks are being swallowed at ASK.
It would have been worse. I am very happy the hold is lift. Stoll and the team definitely handle the hold very well.
Blue sky from here.
i don't think higher does will be anything near the 800. Those dosing should be included in previous tox studies.
i was wondering the same thing. good that fda lift the hold anyway..gee
If FDA lifts the hold, it won't be a spike. It will definitely be a start of an uptrend.
I will be seriously shocked if any stock sale done under $4.5.
We will see.
The recent finding in High Impact alone added very significant value to the platform.
Will cortex ever been in billion market cap!
One more WEEK.
will FDA uses all 30 days?
but it should be other way around. If FDA sees the problem, wouldn't they reply already.
15 more days to go.
We will have our date.
The only difference is we don't have an A.. cheers.
They shouldn't. But that would depend on relationship between those warrant holders and Cortex. Do they want to see there shares diluted by some other.
Remember, we do have some warrant exerises prior to the hold which was prior to the BP deal.
gfp927z, are u back in yet? or still happy with your CD? TIA.
Any chance the hold will be lifted sooner than 30 days? 30 days is the max right?
I mean we are not talking about lots of data here. The concern is not even related to human trial. Just dozens of monkeys.
Any comments?
I think/hope no PIPE, the warrants can bring in 25million. The exersice price for warrant is 3.02, so it's possible cash is coming in as we speak.
I agree that with more cash on hand, the BP deal may end up better. Kind of short term pain, longer term gain.
PIPE doesn't really matter on longer term basis. As long as the hold is lifted on time, we will be fine.
BP deal before year end or not really depends on what state the talk was in prior to the hold.
neuroinv, are you still confidence about double digit by year end?
thanks.
just 500 K volume?
I won't be suprise to see something close to 2million.
Oh, my bad. Please pardon me.
I have two brokerage accounts:
one says OI of 5,120, the other says: 600.